According to the Wall Street Journal, Rite Aid, the U.S. pharmacy chain, is considering the possibility of another bankruptcy due to its recent financial restructuring failing to establish a sustainable direction for the company. The pharmacy chain is exploring the option of selling some or all of its businesses as an alternative to filing for Chapter 11 bankruptcy, as reported by sources familiar with the situation. If a sale does not come to fruition through bankruptcy or otherwise, Rite Aid could face the potential of further reducing its store presence through liquidation. Rite Aid has yet to respond to a request for comment from Reuters. Following its emergence from Chapter 11 bankruptcy last year, the Pennsylvania-based company, now privately held, underwent a successful financial overhaul. During bankruptcy proceedings, Rite Aid closed numerous stores, divested its pharmacy benefit unit Elixir, and reached agreements with creditors including McKesson and other lenders. After posting $750 million in losses and $24 billion in revenue for the fiscal year ending March 2023, Rite Aid filed for Chapter 11 in October 2023 when it operated 2,000 pharmacies.